Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling.

Cell metabolism - 1 Dec 2005

Boyce Brendan F, Xing Lianping, Chen Di

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Bone and Bones
Share to Bone Remodeling
Share to Osteoblasts

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteoprotegerin

Share to Receptors, Cytoplasmic and Nuclear

Share to Receptors, Tumor Necrosis Factor

Share to Wnt Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 16330319
DOI: 10.1016/j.cmet.2005.11.011
PMCID: PMC2647984

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling.PMID 16330319Read ↗

[OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].Semantic proximity Read ↗

Wnt/β-catenin signaling pathway: proteins' roles in osteoporosis and cancer diseases and the regulatory effects of natural compounds on osteoporosisSemantic proximity Read ↗

Osteocytic signalling pathways as therapeutic targets for bone fragilitySemantic proximity Read ↗

Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone HomeostasisSemantic proximity Read ↗

Biology of the RANKLâ€“RANKâ€“OPG System in Immunity, Bone, and BeyondSemantic proximity Read ↗

Disabling of Receptor Activator of Nuclear Factor-κB (RANK) Receptor Complex by Novel Osteoprotegerin-like Peptidomimetics Restores Bone Loss in VivoSemantic proximity Read ↗

The Regulation of Bone Metabolism and Disorders by Wnt Signaling.Semantic proximity Read ↗

SOST/sclerostin, an osteocyte-derived negative regulator of bone formationSemantic proximity Read ↗

The Therapeutic Potential of the Wnt Signaling Pathway in Bone DisordersSemantic proximity Read ↗

Osteoporosis - a current view of pharmacological prevention and treatment.Semantic proximity Read ↗

Bone: Wnt--1-a key player in the regulation of human bone mass?Semantic proximity Read ↗

Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.